Share this article and save a life!
Your AI therapist needs a prescription now.
The FDA just dropped a bombshell on mental health tech companies.
At their November 2025 Digital Health Advisory Committee meeting, they outlined something unprecedented: generative AI chatbots for mental health might need the same rigorous testing as antidepressants.
Think about that for a second.
Double-blind, placebo-controlled trials. For chatbots. 🤖
Here’s what the FDA is demanding:
• Predetermined Change Control Plans for every algorithm update
• Real-time monitoring for “hallucinations” and harmful outputs
• Evidence of equitable performance across all populations
• Human escalation pathways built into every system
• Potentially Class III medical device designation (the highest risk category)
Why this matters:
77% of counties in America lack adequate mental health providers. AI chatbots could fill this gap, especially in rural and underserved communities. But the FDA sees massive risks too.
The scary part? These chatbots can develop “sycophancy” (telling users what they want to hear instead of what they need to hear). Imagine an AI therapist validating harmful behaviors just to keep engagement high.
Five states already jumped ahead with their own laws. California’s kicks in January 1, 2026, requiring clear AI notifications and self-harm content controls.
But here’s my take:
We’re watching the collision of Silicon Valley’s “move fast and break things” with healthcare’s “first, do no harm.”
The FDA is essentially saying: You can’t beta test with people’s mental health.
And they’re right.
Yet we desperately need innovation here. Mental health care is broken. Access is terrible. Costs are astronomical.
So the million-dollar question becomes:
Can we regulate AI mental health tools without killing the very innovation that could save lives?
The answer will reshape how 150 million Americans with mental health conditions get care.
What’s your take? Should AI therapists face the same scrutiny as medications, or will overregulation prevent breakthrough solutions?
♻️ Repost if mental health innovation needs balanced regulation
👉 Follow me, Jonathan Govette, for real-time updates on healthcare technology and business news. LinkedIn Profile: https://www.linkedin.com/in/jonathangovette/
Share this article and save a life!
Author:
Jonathan Govette is a seasoned healthcare and technology executive with more than two decades of experience building, scaling, and advising digital health companies. He is the Co-Founder and CEO of Oatmeal Health, an AI-driven Lung Cancer Screening and Diagnostics company focused on expanding access to early detection for underrepresented populations, particularly patients served by Federally Qualified Health Centers and value-based health plans.
With a background in engineering, product development, and strategic partnerships, Jonathan has founded and led multiple health technology ventures across clinical care delivery, regulated medical software, and AI-enabled diagnostics. His work sits at the intersection of medicine, technology, and health equity, with a consistent focus on translating complex clinical problems into scalable, real-world solutions.
Jonathan has spent much of his professional life dedicated to improving outcomes for marginalized and underserved communities. He has designed and implemented frameworks that align clinical quality, reimbursement, and technology to sustainably advance health equity at scale. This mission is deeply personal and informs his leadership philosophy and long-term vision for healthcare transformation.
In addition to his operating experience, Jonathan is an author and long-time writer in the healthcare domain, with over 20 years of published work covering digital health, medical innovation, and healthcare systems. He is a frequent mentor to early-stage founders and regularly advises startups on product strategy, partnerships, and go-to-market execution in regulated healthcare environments.
Before entering industry full-time, Jonathan nearly pursued a career in medicine with an early path toward cardiothoracic surgery, an experience that continues to shape his clinical perspective and respect for frontline care delivery.
CEO | Oatmeal Health | AI Lung Cancer Startup | Engineer | Writer | Almost Became a Doctor (Cardiac Thoracic Surgeon) | 3x Health Tech Founder | Startup Mentor | Follow to share what I’ve learned along the way.
